Search Results 2661-2670 of 13405 for monoclonal antibody

1. REgulatory T Cell Therapy To Achieve Immunosuppression REduction - Mayo Clinic

   Subjects with current or historic donor specific antibodies. 6. Body Mass Index (BMI) of \< 16 kg/m2 or \> 38 kg/m2 per SOC pre-transplant evaluation. 7 ...

2. A Study Of Andecaliximab In Participants With Fibrodysplasia Ossificans Progressiva (FOP) - Mayo Clinic

   * Whether the body makes antibodies against the study drug (which could make the drug less effective or could lead to side effects). Participation ...

3. News Releases

   News Releases · AI-assisted approach helps novice users capture heart ultrasound images, identify aortic stenosis featured · 5 subtypes of common liver disease ...

4. LMN-201 For Prevention Of C. Difficile Infection Recurrence - Mayo Clinic

   ), or another antibody against C. difficile toxin(s) 2. C. difficile vaccine 3. SER-109 (Seres Therapeutics) 4. CP101 (Finch Therapeutics) 5. VE303 (Vedanta ...

5. Study of Efficacy and Safety of CTL019 in Adult ALL Patients - Mayo Clinic

   ... antibodies such as anti-TNF-α, anti-IL6 or anti-IL6R). Topical steroids for localized treatment of GVHD are allowed. Anti T-cell Directed Therapy ...

6. Medical Research & Education - Mayo Clinic News Network

   ROCHESTER, Minn. — Mayo Clinic researchers have estimated the risk that pancreatic cysts with worrisome or high-risk features will progress to pancreatic cancer ...

7. Acute lymphocytic leukemia - Doctors and departments - Mayo Clinic

   Associated Procedures. Bispecific antibody therapy · Bone marrow biopsy · Bone marrow transplant · Cancer treatment · CAR-T cell therapy · Chemotherapy · CT ...

8. A Study To Evaluate The Safety, Pharmacokinetics, And Anti-tumor Activity Of LYT-200 Alone And Combined With Chemotherapy Or Tislelizumab To Treat Patients With Metastatic Solid Tumors - Mayo Clinic

   History of severe allergic, anaphylactic, or other hypersensitivity reactions to chimeric or humanized antibodies or fusion proteins. Significant vascular ...

9. A Phase I, Multi-Center, Open Label, Dose De-escalation And Expansion Study Of Gemcitabine And Cisplatin With AG120 Or Pemigatinib For Advanced Cholangiocarcinoma - Mayo Clinic

   Ivosidenib and pemigatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving gemcitabine and cisplatin with ...

10. Ipilimumab With Or Without Talimogene Laherparepvec In Unresected Melanoma - Mayo Clinic

    Subjects previously treated with anti-program death-1 (PD1) or anti-cytotoxic T-lymphocyte associated antigen 4 (CTLA-4) antibodies must not have ...